We recently discovered the tetracycline destructases, a new family of flavoenzymes capable of degrading tetracycline through novel mechanisms, distinct from the canonical resistance strategies of efflux or ribosomal protection. The rationale for the proposed research is that increasing antibiotic resistance in pathogens is a public health emergency, fed by a potent reservoir of under-characterized antibiotic resistance genes found in benign environmental bacteria. The central motivation for this proposal is to comprehensively understand and model the sequence-structure-function-substrate space for this novel class of tetracycline resistance enzymes, so as to design strategies to mitigate their clinical impact before they widely disseminate into important pathogens. Guided by strong preliminary data, this proposal will pursue three independent yet complementary specific aims: 1) Elucidate the mechanism of action of the tetracycline destructases, 2) Characterize the evolutionary landscape of the tetracycline destructases, and 3) Rationally design and synthesize tetracycline destructase inhibitors.
The first aim will test the hypothesis that the tetracycline destructases degrade tetracycline via two independent and potentially novel mechanisms that are controlled at the sequence- structure level. Crystallography and enzymology will be used to comprehensively elucidate the structure and mechanism of action of the tetracycline destructases.
The second aim examines the hypothesis that the tetracycline destructases originated as biosynthetic flavoenzymes, and are poised to become clinical threats.
This aim will explore the sequence-structure-function space, model the fitness landscape, and elucidate cross-resistance mechanism interactions of the tetracycline destructases.
The third aim proposes the hypothesis that susceptibility to tetracycline can be restored by inhibition of the tetracycline destructases. This will be achieved by the structure-guided design, synthesis, and characterization of tetracycline destructase inhibitors. This proposal is innovative because our integrated and complementary research team will test novel concepts in emerging antibiotic resistance, and apply multi-disciplinary technological innovation to comprehensively study and target tetracycline destructases. The proposed research is significant because in the United States alone, more than two million people every year suffer an antibiotic-resistant infection, leading to at least 23,000 deaths and an estimated $55 billion of excess healthcare-related costs. Antibiotic resistance has steadily increased in pathogenic and benign bacteria since the introduction of antibiotics to the clinic and in agriculture. Tetracycline destructases are likely candidates for dissemination to the clinic, potentially compromising new tetracycline derivatives and motivating deep mechanistic analysis of their activities. The proposed research is impactful because it will (1) advance fundamental understanding of the evolutionary origins of anti- biotic resistance, (2) assess the clinical threat posed by environmental resistance genes, and (3) devise inhibitor-based solutions to the problem of antibiotic resistance through the lens of the tetracycline destructases.

Public Health Relevance

The proposed studies address an important yet under-investigated area of emerging resistance genes of environmental origin with novel enzymatic activities against key antibiotics, which have the potential to severely compromise treatment of bacterial pathogens. The proposed research will identify new avenues for intervention which are relevant to public health, because current treatment options for increasingly drug resistant bacteria are failing. This project is relevant to the NIH's mission of developing fundamental knowledge that may reduce the burden of human disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI123394-03
Application #
9421548
Study Section
Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section (DDR)
Program Officer
Ernst, Nancy L
Project Start
2016-02-11
Project End
2021-01-31
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Washington University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Adu-Oppong, Boahemaa; Gasparrini, Andrew J; Dantas, Gautam (2017) Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes. Ann N Y Acad Sci 1388:42-58
Park, Jooyoung; Gasparrini, Andrew J; Reck, Margaret R et al. (2017) Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes. Nat Chem Biol 13:730-736
Crofts, Terence S; Gasparrini, Andrew J; Dantas, Gautam (2017) Next-generation approaches to understand and combat the antibiotic resistome. Nat Rev Microbiol 15:422-434
Forsberg, Kevin J; Patel, Sanket; Wencewicz, Timothy A et al. (2015) The Tetracycline Destructases: A Novel Family of Tetracycline-Inactivating Enzymes. Chem Biol 22:888-97